NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1891369963 MBBS
Verify on CMS → Deesha Shah, MBBS
Endocrinology, Diabetes & Metabolism Physician in Gainesville, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
153
Medicare Part D claims · 27 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Deesha Shah, MBBS filed 153 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Gainesville, Florida, prescribing 73% generic.
- 153
- Part D claims, 2024
- 73%
- generic prescribing
- ≥34th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Deesha Shah, MBBS
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1891369963), first enumerated 05/13/2021.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 153 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Deesha Shah, MBBS's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1891369963 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-RECENT · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1891369963
- ENUM-RECENT 2021
- TAX-MID 8K Endocrinology, Diabetes
- RX-LIGHT 153
- BOOK-LIGHT 538 in Florida
- PHOTO-ENUM Kulsum Madani · 2021
Deesha Shah, MBBS's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
153 ≥ 34th percentile 34% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Deesha Shah, MBBS practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Deesha Shah, MBBS?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
153 94% vs specialty avg
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1891369963 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MBBS |
| Gender | Female |
| NPI Issued | 05/13/2021 |
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Deesha Shah, MBBS. To verify Deesha Shah, MBBS's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Deesha Shah, MBBS - brand share 27.0%
Endocrinology, Diabetes & Metabolism Physician average
27% brand-name claims vs 73% generic, on 153 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
153
Total Claims
$69K
Total Drug Cost
27
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 269.133
- Total Day Supply
- 7,837
- Brand vs Generic
- 27% brand / 73% generic
- Brand Drug Cost
- $67K
- Generic Drug Cost
- $1K
Patient Demographics
- Average Patient Age
- 72.4 years
- Avg HCC Risk Score
- 1.51
- Gender Split
- 52% female / 48% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Deesha Shah, MBBS prescribes most
Top Medicare Part D drugs by claim count, 2024
- Gabapentin
Gabapentin
14 claims
- Metoprolol Tartrate
Metoprolol Tartrate
14 claims
- Lisinopril
Lisinopril
12 claims
- Metformin Hcl Er
Metformin Hcl Er
11 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
11 claims
| Drug | Claims |
|---|---|
| Gabapentin | 14 |
| Metoprolol Tartrate | 14 |
| Lisinopril | 12 |
| Metformin Hcl Er Metformin Hcl | 11 |
| Rosuvastatin Calcium | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in FL →
All providers in Florida →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Deesha Shah, MBBS fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Deesha Shah, MBBS's 153 claims are below the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Shah, both outside Florida so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2021)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Shah.
One of 538 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.
Dr. Ejigayehu Abate
MD
Jacksonville, FL
Dr. Susan Abend
M.D.
Sarasota, FL
Dr. Daisy Acevedo Morales
MD
South Miami, FL
Dr. Brenda Acosta Ashby
MD
Doral, FL
Adriane Adami
APRN
Panama City, FL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Deesha Shah, MBBS's specialty? ▼
Deesha Shah, MBBS specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Gainesville, Florida. Credentials: MBBS.
How much does Deesha Shah, MBBS prescribe under Medicare Part D? ▼
In 2024, Deesha Shah, MBBS wrote 153 Medicare Part D claims totaling $69K in drug costs for 27 beneficiaries.
Where is Deesha Shah, MBBS located? ▼
Deesha Shah, MBBS is located at 1600 SW ARCHER RD, Gainesville, FL, 32610. Phone: (352) 273-8662.
What is Deesha Shah, MBBS's NPI number? ▼
Deesha Shah, MBBS's National Provider Identifier (NPI) is 1891369963, issued on 05/13/2021.
Does Deesha Shah, MBBS prescribe more brand-name or generic drugs? ▼
Deesha Shah, MBBS's prescribing is 27% brand-name and 73% generic drugs by claim count, with $67K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Deesha Shah, MBBS prescribe most often? ▼
Based on 2024 Medicare Part D data, Deesha Shah, MBBS's most frequently prescribed drugs include Gabapentin, Metoprolol Tartrate, Lisinopril. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Deesha Shah, MBBS accept Medicare? ▼
Deesha Shah, MBBS appears in CMS Medicare data with 153 Part D claims and 27 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Deesha Shah, MBBS's credentials? ▼
Deesha Shah, MBBS's NPI is 1891369963 with credentials MBBS. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.